Speaker

Adam Mendelsohn

Co-Founder & Chief Executive Officer, Vivani

Adam Mendelsohn, Co-Founder & Chief Executive Officer at Vivani, is speaking at 3rd Obesity & Weight Loss Drug Development Summit West (San Diego, United States of America, 9–10 Dec 2026) in the session “Beyond Weekly Injections: Reimagining Long-Term Obesity Treatment Through Ultra-Long-Acting Drug Delivery”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

3rd Obesity & Weight Loss Drug Development Summit West
9–10 Dec 2026San Diego, United States of America
- SpeakerBeyond Weekly Injections: Reimagining Long-Term Obesity Treatment Through Ultra-Long-Acting Drug Delivery
- SpeakerFireside Chat: Aligning Route & Frequency of Administration with Real-World Patient Needs & Treatment GoalsWith Patrick Griffin, Maria Wilson

More speakers at 3rd Obesity & Weight Loss Drug Development Summit West

Mini Balakrishnan
Vice President, Biology, Biomea Fusion
Jeremiah Bearss
Vice President - Clinical Development, Biolexis Therapeutics
Ashok Bhandari
Executive Vice President & Chief Discovery Officer, Protagonist Therapeutics
Charles Harris
Associate Vice President, Eli Lilly & Co.
Hans Keirstead
Chairman, Immunis
Greg Luerman
Vice President, Research & Partnerships, Curi Bio

See all 9 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Adam Mendelsohn, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].